Cargando…
Co-Treatment of Chloroquine and Trametinib Inhibits Melanoma Cell Proliferation and Decreases Immune Cell Infiltration
Autophagy is characterized as a cytoprotective process and inhibition of autophagy with medicinally active agents, such as chloroquine (CQ) is proposed as a prospective adjuvant therapy for cancer. Here, we examined the preclinical effects of CQ combined with the MEK inhibitor trametinib (TRA) on me...
Autores principales: | Degan, Simone, May, Brian L., Jin, Yingai J., Hammoda, Manel Ben, Sun, Huiying, Zhang, Guoqiang, Wang, Yan, Erdmann, Detlev, Warren, Warren, Zhang, Jennifer Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282877/ https://www.ncbi.nlm.nih.gov/pubmed/35847840 http://dx.doi.org/10.3389/fonc.2022.782877 |
Ejemplares similares
-
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
por: Brase, Jan C., et al.
Publicado: (2021) -
Expression Signatures of Cisplatin- and Trametinib-Treated Early-Stage Medaka Melanomas
por: Klotz, Barbara, et al.
Publicado: (2019) -
Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells
por: Osrodek, Marta, et al.
Publicado: (2020) -
Trametinib: A Targeted Therapy in Metastatic Melanoma
por: Hoffner, Brianna, et al.
Publicado: (2018) -
Trametinib: a MEK inhibitor for management of metastatic melanoma
por: Lugowska, Iwona, et al.
Publicado: (2015)